John Adams, Jr
John Adams, Jr. has served as a member of our board of directors since April 2015. Mr. Adams has served as Chief Executive Officer of Adams Respiratory Therapeutics Inc. and served as its President since 2003. Adams Respiratory developed Mucinex and was subsequently acquired by Reckitt Benckiser for $2.3 billion. Mr. Adams founded and manages Legacy Capital Partners, LLC, an investment management and private equity firm focused on healthcare technology and pharmaceutical development. Mr. Adams holds a BA in Business from Austin College.